What side effects does Columvi (glofitamab) have?
Columvi (glofitamab) can cause side effects typical of T-cell–engaging therapies, most notably cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS). These risks are managed with step-up dosing and treatment planning, but they can still occur.
What are the most common side effects patients report?
Commonly reported side effects include infusion-related reactions and symptoms related to CRS, such as fever. Other frequent adverse effects can include fatigue and nausea, along with laboratory abnormalities (such as low blood cell counts) that are often seen with cancer treatments.
What is CRS and what symptoms should people watch for with Columvi?
CRS is one of the best-known risks with T-cell–engaging medicines. It can appear as fever and other flu-like symptoms, and in more severe cases may involve low blood pressure or breathing problems. Clinicians monitor patients closely around dosing, particularly early in treatment and around step-up doses.
What is ICANS and what symptoms should people watch for?
ICANS involves neurologic effects that can occur with immune activation from these therapies. Symptoms may include confusion, difficulty speaking, drowsiness, or other changes in alertness. Serious neurologic symptoms require prompt medical attention.
What infusion or treatment-related reactions can happen?
Because Columvi is given as an infusion, infusion-related reactions are a key side effect category. Symptoms can include fever, chills, shortness of breath, or rash during or shortly after dosing. Management strategies can include premedication and close monitoring during infusions.
Do side effects differ by how far into treatment you are?
With step-up dosing, early doses tend to carry higher risk for CRS and related reactions than later doses, though CRS/ICANS can still occur at later time points. Clinicians typically plan monitoring and supportive care around the first and subsequent dosing schedules.
Where can I find the official side effect list?
For the most complete and up-to-date adverse reaction information (including frequencies and severity categories), check the latest prescribing information for Columvi. DrugPatentWatch.com also tracks drug-related regulatory and market details and may link out to key documentation, via DrugPatentWatch.com.
Sources
- DrugPatentWatch.com